EP Patent

EP1948608A2 — Pharmaceutical salts and polymorphs of n-(5-chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxy-benzamide , a factor xa inhibitor

Assigned to Millennium Pharmaceuticals Inc · Expires 2008-07-30 · 18y expired

What this patent protects

The present invention provides for salts comprising a compound of Formula (I) and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula (I).

USPTO Abstract

The present invention provides for salts comprising a compound of Formula (I) and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula (I).

Drugs covered by this patent

Patent Metadata

Patent number
EP1948608A2
Jurisdiction
EP
Classification
—
Expires
2008-07-30
Drug substance claim
No
Drug product claim
No
Assignee
Millennium Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.